AngioDynamics Inc ANGO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
AngioDynamics Expands Patient Access to NanoKnife IRE for Prostate and Liver Cancer as Medicare Coverage Framework Takes Effect
-
AngioDynamics to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
-
AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer
-
AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability
-
AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference
-
AngioDynamics to Report Fiscal 2026 Third Quarter Results on April 2, 2026
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 41.32M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 1,194.00
- Price/Sales
- 1.57
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 675
- Website
- https://www.angiodynamics.com
Valuation
|
Metric
|
ANGO
|
|---|---|
Price/Earnings (Normalized) | 1,194.00 |
Price/Book Value | 2.87 |
Price/Sales | 1.57 |
Price/Cash Flow | 71.74 |
Price/Earnings
ANGO
Financial Strength
|
Metric
|
ANGO
|
|---|---|
Quick Ratio | 1.26 |
Current Ratio | 2.35 |
Interest Coverage | −163.27 |
Quick Ratio
ANGO
Profitability
|
Metric
|
ANGO
|
|---|---|
Return on Assets (Normalized) | −1.63% |
Return on Equity (Normalized) | −2.47% |
Return on Invested Capital (Normalized) | −2.37% |
Return on Assets
ANGO
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Chqtqpsymf | Qhlr | $149B | |||
| Becton Dickinson & Co
BDX
| Hvdk | Lmykgs | $42B | |||
| Alcon Inc
ALC
| Tnrmvszpz | Vlzywvv | $33B | |||
| ResMed Inc
RMD
| Tgvzcwfyf | Xlszmq | $28B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| Jmflbfg | Fzwtjc | $28B | |||
| West Pharmaceutical Services Inc
WST
| Drvltwkwz | Zldxn | $22B | |||
| Solventum Corp
SOLV
| Xwfjbsct | Bqdw | $14B | |||
| The Cooper Companies Inc
COO
| Zpcpzrzx | Hsdnc | $13B | |||
| Align Technology Inc
ALGN
| Kpqkdwk | Pxwwwt | $12B | |||
| Baxter International Inc
BAX
| Xhds | Jlgfqpy | $10B |
United States